awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50119733-9C061B45-BCD4-4050-9C9F-B4AE9732F6A7
Q50119733-9C061B45-BCD4-4050-9C9F-B4AE9732F6A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50119733-9C061B45-BCD4-4050-9C9F-B4AE9732F6A7
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval.
P2860
Q50119733-9C061B45-BCD4-4050-9C9F-B4AE9732F6A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50119733-9C061B45-BCD4-4050-9C9F-B4AE9732F6A7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c05c1c212f3fad8a7d9a0c0a66879be452e8a7d
P2860
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.